Chemical Structure : VU661013
CAS No.: 2131184-57-9
Catalog No.: PC-35655Not For Human Use, Lab Use Only.
VU661013 (VU-661013) is a novel potent, selective MCL-1 inhibitor with Ki of 97 pM (human MCL-1) in TR-FRET assay, shows no significant inhibition on BCL-xL (Ki>40 uM) or BCL-2 (Ki=0.73 uM).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $458 | In stock | |
10 mg | $758 | In stock | |
25 mg | Get quote | ||
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
VU661013 (VU-661013) is a novel potent, selective MCL-1 inhibitor with Ki of 97 pM (human MCL-1) in TR-FRET assay, shows no significant inhibition on BCL-xL (Ki>40 uM) or BCL-2 (Ki=0.73 uM).
VU661013 de-stabilizes BIM/MCL-1 association, leads to apoptosis in AML.
VU661013 is active in venetoclax-resistant cells and patient derived xenografts.
M.Wt | 712.672 | |
Formula | C39H39Cl2N5O4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(R)-3-(7-chloro-10-(3-(4-chloro-3,5-dimethylphenoxy)propyl)-4-methyl-1-oxo-6-(1,3,5-trimethyl-1H-pyrazol-4-yl)-3,4-dihydropyrazino[1,2-a]indol-2(1H)-yl)-1-methyl-1H-indole-5-carboxylic acid |
1. Ramsey HE, et al. Cancer Discov. 2018 Sep 5. pii: CD-18-0140.
2. Zhao B, et al. Biochemistry. 2018 Aug 14;57(32):4952-4958.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright